Article Text

THU0568 Prevalence and autoimmune rheumatic disease in patients with autoimmune/inflammatory syndrome induced by adjuvants associated to silicone breast implant
  1. O Vera Lastra,
  2. NE Torres-Oliva,
  3. G Medrano-Rodriguez,
  4. MDP Cruz-Dominguez,
  5. J Sepulveda Delgado,
  6. LJ Jara,
  7. G Medina
  1. Internal Medicine, Hospital Especialidades CMN la Raza. Instituto Mexicano Seguro Social, Mexico City, Mexico


Background Autoimmune/inflammatory syndrome induced by adjuvants (ASIA) has been associated with previous exposure to various agents such as silicone implants, which elicit chronic stimulation of the immune system against the prosthetic material and clinical manifestation of autoimmune disease. This is particularly the case in genetically susceptible hosts.

Objectives The aim is to describe de prevalence, family background and main autoimmune rheumatic disease (ARD) associated to silicone breast implant (SBI).

Methods We study a cohort of 150 patients with diagnosis of ASIA associated injection of mineral oil and silicone breast implant (SBI) in a tertiary Hospital, from 2011 to 2016. All patients were evaluated for the fulfilment of ASIA criteria. We only included patients with ASIA criteria associated with SBI plus criteria for an autoimmune rheumatic disease according to The American College of Rheumatology or EULAR. We excluded patient with ASIA and without ARD.

Results There were 17 women patients with mean age 42.4±15.3 years, mean disease duration of disease 8±3. The clinical manifestation post SBI appeared 8±2 years later.

The ARD were systemic sclerosis (SSc) 5, systemic lupus erythematosus (SLE) 3, rheumatoid arthritis (AR) 3, overlap syndrome 2 (SSc plus SS and SLE plus SSc, Sjogren syndrome 1, Takayasu arteritis 1, Still disease 1, antiphospholipid syndrome 1, and 3 patients also had secondary fibromyalgia. Five Patients had more than 2 autoantibodies, 4 patients had relatives with an ARD. All patients are being treated according to the ARD (steroids plus immunosuppressive 8 patients, immunosuppressive 7, and only steroids 2), in 4 patients the prosthesis were withdrawn with improvement of clinical manifestations.

Conclusions We found a prevalence of ASIA associated to SBI of 11%. The main ARD were SSc, SLE and RA. In these cases of ASIA associated with SBI some had genetic predisposition to ARD. The use of SBI is not recommended in women who have a family history of ARD.


  1. Colaris MJ et al. Two hundred cases of ASIA syndrome following silicone implants: a comparative study of 30 years and rewiew of current literature. Immunol Res 2016 Jul 13.

  2. Jara LJ, et al. Severe manifestation of autoimmune syndrome induced by adjuvants (Shoenfeld's syndrome) Immunol Res Jul 13.

  3. Watad et a. Autoimmune/Inflammatory induced by adjuvants (Shoenfeld's syndrome) UN update. Lupus 2017 Jan 1.


Disclosure of Interest None declared

Statistics from

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.